European Firms Adapting To Coronavirus Challenges
Executive Summary
Companies across Europe are dealing with new challenges stemming from the coronavirus outbreak, particularly with supply issues due to increased demand. This article details the responses of five consumer health players in the region: Reckitt Benckiser, Zentiva, Vitabiotics, Alliance Pharma and BioGaia.
You may also be interested in...
COVID-19 Prompts OTC Sales Restrictions Across Europe
Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.
RB Implores Australian Consumers To Stop Panic Buying Its Brands
Reckitt Benckiser has seen an unprecedented increase in demand for its OTCs since the COVID-19 outbreak and is urging Australian consumers to stop panic buying so its partners can restock stores.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.